We first reported data from the results of the RTOG 0938 trial in January 2016 when they were presented at the Genitourinary Cancers Symposium in that year. These results have now been formally published, and there are some changes to the data on publication, so Allen Edel has provided an update. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: body, hypofractionated, radiation, SBRT, stereotactic, toxicity | Leave a comment »
A recent report on Renal & Urology News discusses long-term follow-up data from a cohort of > 2,600 prostate cancer patients who were followed from diagnosis for up to 10 years until their deaths. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | 2 Comments »
One has to sign up to become a member of the UroToday web site, but there is no cost involved, and an attractive feature for prostate cancer patients is the regular, relatively brief, video-recorded interviews with experts on recent, specific issues. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: expert, interview, opinion, video | Leave a comment »
An interesting article published a couple of week’s ago in the Medical Journal of Australia reports on “real world issues” related to the implementation of active surveillance (AS) in Oz. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, AS, Australia, clinical, practice, protocol, standard, surveillance | 2 Comments »
In a new article in the Journal of Urology, researchers at Johns Hopkins Medical Center in Baltimore have again expressed their opinion that it would be inappropriate to rename low-risk Gleason 6 disease as something other than “cancer”. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: cancer, IMPACT, not, opinion, terminology | 3 Comments »
It will come as no particular surprise that men who have had complications after a prior biopsy tend to be less enthusiastic when it is suggested that they need another one. However, … … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, compliance, complication, repeat | 7 Comments »
Someone asked the sitemaster yesterday about a new test for risk of prostate cancer called Prostac® and where he could access this. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: development, Diagnosis, NucleoBio, Prostac, risk, test | Leave a comment »
